CLINICAL_TRIALS
trial_result
· 2022-01-20
Clinical Trial Update: Bioequivalence Study of Paroxetine and PAXIL Under Fasting Conditions in Healthy Mexican Participants [Phase 1]
Summary
Phase 1 bioequivalence study of paroxetine and PAXIL under fasting conditions in healthy Mexican participants completed; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: GlaxoSmithKline | Conditions: Anxiety Disorders | Phase 1 | Status: COMPLETED | Results posted: 2022-01-20